Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.17843/rpmesp.2020.374.5976 http://scihub22266oqcxt.onion/10.17843/rpmesp.2020.374.5976 33566899!ä!33566899 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33566899&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Rev+Peru+Med+Exp+Salud+Publica 2020 ; 37 (4): 611-619 Nephropedia Template TP {{tp|p=33566899|t=2020. COVID-19 en pacientes con cancer: revision sistematica |pdf=|usr=}}{{33566899}} gab.com Text COVID-19 en pacientes con cancer: revision sistematica JO: Rev Peru Med Exp Salud Publica http://www.kidney.de/pget.php?&tw=1&pmid=33566899 #FOAvip OBJECTIVE: Development of severe disease and death from COVID-19 is more frequent in patients with comorbidities. Some studies report an increased frequency of severe COVID-19 in cancer patients. This review aims to describe the risk of infection and developing severe COVID-19 in cancer patients. MATERIALS AND METHODS: A systematic review was carried out through an exhaustive search of literature in PubMed and Scopus until May 2020. A secondary search was performed to include more studies. RESULTS: The initial search identified 2,192 records, which included 17 publications with at least 10 infected cancer patients. Also, 5 articles were added from the additional search of the references cited by those 17 publications. Ten publications were from Chinese authors. Data analysis showed that COVID-19 infection is more frequent in cancer patients, and frequent therapeutic visits to the healthcare facility may be the cause. The presence of neoplasia predisposed patients to develop severe disease. Advanced age, associated comorbidities, advanced malignancy, and the presence of serum inflammatory markers increased the risk of developing severe disease. Initial studies indicate that the use of systemic treatment may also be a predisposing factor. CONCLUSIONS: The risk of becoming infected by COVID-19 and developing severe disease is higher in the oncological population. Twit Text FOAVip COVID-19 en pacientes con cancer: revision sistematica ????Rev Peru Med Exp Salud Publica http://www.kidney.de/pget.php?&tw=1&pmid=33566899 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33566899 #FOAvip English Wikipedia <ref>{{Cite pmid|33566899}}</ref> COVID-19 en pacientes con cancer: revision sistematica #MMPMID33566899 Castaneda CA; Castillo M; Rojas-Vilca JL; Fuentes H; Gomez HL Rev Peru Med Exp Salud Publica 2020[Oct]; 37 (4): 611-619 PMID33566899show ga OBJECTIVE: Development of severe disease and death from COVID-19 is more frequent in patients with comorbidities. Some studies report an increased frequency of severe COVID-19 in cancer patients. This review aims to describe the risk of infection and developing severe COVID-19 in cancer patients. MATERIALS AND METHODS: A systematic review was carried out through an exhaustive search of literature in PubMed and Scopus until May 2020. A secondary search was performed to include more studies. RESULTS: The initial search identified 2,192 records, which included 17 publications with at least 10 infected cancer patients. Also, 5 articles were added from the additional search of the references cited by those 17 publications. Ten publications were from Chinese authors. Data analysis showed that COVID-19 infection is more frequent in cancer patients, and frequent therapeutic visits to the healthcare facility may be the cause. The presence of neoplasia predisposed patients to develop severe disease. Advanced age, associated comorbidities, advanced malignancy, and the presence of serum inflammatory markers increased the risk of developing severe disease. Initial studies indicate that the use of systemic treatment may also be a predisposing factor. CONCLUSIONS: The risk of becoming infected by COVID-19 and developing severe disease is higher in the oncological population. |Age Factors[MESH] |COVID-19/*epidemiology/mortality/physiopathology[MESH] |Comorbidity[MESH] |Humans[MESH] |Inflammation Mediators/*blood[MESH] |Neoplasms/*complications[MESH] |Risk Factors[MESH]COVID-19 en pacientes con cancer: revision sistematica (epmc).pdf DeepDyve Pubget Overpricing